<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hipertensión &#187; Valsartán</title>
	<atom:link href="https://temas.sld.cu/hipertension/tag/valsartan/feed/" rel="self" type="application/rss+xml" />
	<link>https://temas.sld.cu/hipertension</link>
	<description>Sitio web dedicado a la hipertensión en Cuba</description>
	<lastBuildDate>Fri, 06 Jun 2025 14:42:55 +0000</lastBuildDate>
	<language>es-ES</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Effects of valsartan on progression of kidney disease in Japanese hypertensive patients with advanced, predialysis, chronic kidney disease: Kanagawa Valsartan Trial (KVT)</title>
		<link>https://temas.sld.cu/hipertension/2013/03/15/effects-of-valsartan-on-progression-of-kidney-disease-in-japanese-hypertensive-patients-with-advanced-predialysis-chronic-kidney-disease-kanagawa-valsartan-trial-kvt/</link>
		<comments>https://temas.sld.cu/hipertension/2013/03/15/effects-of-valsartan-on-progression-of-kidney-disease-in-japanese-hypertensive-patients-with-advanced-predialysis-chronic-kidney-disease-kanagawa-valsartan-trial-kvt/#comments</comments>
		<pubDate>Fri, 15 Mar 2013 16:17:19 +0000</pubDate>
		<dc:creator><![CDATA[hipertension]]></dc:creator>
				<category><![CDATA[Propuestas del editor]]></category>
		<category><![CDATA[Japón]]></category>
		<category><![CDATA[Valsartán]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/hta/?p=2453</guid>
		<description><![CDATA[Effects of valsartan on progression of kidney disease in Japanese hypertensive patients with advanced, predialysis, chronic kidney disease: Kanagawa Valsartan Trial (KVT) Por: Takashi Yasuda, Masayuki Endoh, Daisuke Suzuki, Asio Yoshimura, Terukuni Ideura, Kozo Tamura, Kouju Kamata, Yoshiyuki Toya, Satoshi Umemura y Kenjiro Kimura for the KVT Study Group. Hypertension Research (2013) 36, 240–246. Suppression [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/hipertension/2013/03/15/effects-of-valsartan-on-progression-of-kidney-disease-in-japanese-hypertensive-patients-with-advanced-predialysis-chronic-kidney-disease-kanagawa-valsartan-trial-kvt/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cuba dispondrá de otro medicamento contra la hipertensión.</title>
		<link>https://temas.sld.cu/hipertension/2012/05/25/cuba-dispondra-de-otro-medicamento-contra-la-hipertension/</link>
		<comments>https://temas.sld.cu/hipertension/2012/05/25/cuba-dispondra-de-otro-medicamento-contra-la-hipertension/#comments</comments>
		<pubDate>Fri, 25 May 2012 16:17:08 +0000</pubDate>
		<dc:creator><![CDATA[hipertension]]></dc:creator>
				<category><![CDATA[Propuestas del editor]]></category>
		<category><![CDATA[Valsartán]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/hta/?p=1523</guid>
		<description><![CDATA[Cuba dispondrá de otro medicamento contra la hipertensión. El Centro de Investigación y Desarrollo de Medicamentos (CIDEM), de conjunto con los Laboratorios NOVATEC, en La Habana, desarrollan un nuevo fármaco cubano denominado Valsartán tableta, para el tratamiento de la hipertensión arterial. La jefa del proyecto de investigación, la Máster Iverlis Díaz, aseveró a Radio Reloj [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/hipertension/2012/05/25/cuba-dispondra-de-otro-medicamento-contra-la-hipertension/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
